Urinary cystatin C as a specific marker of tubular dysfunction

Area of Science:

• Nephrology
• Clinical Chemistry
• Biomarker Discovery

Background:

• Cystatin C (CST3) is freely filtered by glomeruli and catabolized in tubules.
• Reduced CST3 degradation in tubular disease suggests increased urinary elimination.
• Urinary CST3 monitoring is a potential indicator for tubular dysfunction.

Purpose of the Study:

• Develop and validate an automatic quantitative assay for urinary CST3.
• Assess the clinical relevance of urinary CST3 in kidney disease patients.

Main Methods:

• Utilized a Behring N-Latex Cystatin C kit on a BNII laser nephelometer for assay development.
• Tested the assay's sensitivity (LOD 0.008 mg/L) and precision (CVs < 4%).
• Measured urinary CST3 in patients with kidney tubular disease, glomerular disease, and healthy controls.

Main Results:

• The assay demonstrated high sensitivity and precision.
• Mean urinary CST3 concentrations were significantly elevated in kidney tubular disease patients (4.31 mg/L) compared to controls (0.096 mg/L) and glomerular disease patients (0.106 mg/L).
• Reference values for healthy individuals ranged from 0.03 to 0.18 mg/L.

Conclusions:

• Elevated urinary CST3 accurately detects tubular dysfunction in various nephropathies.
• The assay's compatibility with automated analyzers facilitates its use in routine kidney pathology screening.
• Urinary CST3 serves as a valuable adjunct biomarker for kidney disease assessment, including in emergency settings.